- CYCC -8.11%
All You Need to Know About Cyclacel Pharmaceuticals (CYCC) Rating Upgrade to Buy
Yahoo Finance · 7 days ago
Open | 1.8000 |
High | 1.8000 |
Low | 1.6800 |
Mkt Cap | 2.49M |
P/E (TTM) | N/A |
Div & Yield | N/A & N/A |
Prev. Close | 1.8500 |
52 Wk. Low | 1.3000 |
52 Wk. High | 13.2000 |
Related stocks
Company in Berkeley Heights, United States
Cyclacel Pharmaceuticals Inc. is a biotechnology firm based in Berkeley Heights, New Jersey and Dundee, Scotland, developing cancer treatments. Cyclacel was founded in 1996 by David Lane, PhD. Wikipedia
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | 29k | - |
Net Income | -2.95M | - |
Diluted EPS | -2.27 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | -$1.43 | - |
Q1 2024 | -$4.74 | -$2.27 |
Q4 2023 | -$5.89 | -$6.23 |
S&P FuturesES=F | 5,444.00+16.50 (+0.30%) |
Dow FuturesYM=F | 38,685.00-67.00 (-0.17%) |
Nasdaq FuturesNQ=F | 19,637.25+140.75 (+0.72%) |
Tesla, Inc.TSLA | 177.29+3.88% |
Broadcom Inc.AVGO | 1,495.51+2.36% |
Longeveron Inc.LGVN | 1.8100+120.73% |